Kirschbaum Mark - Insider Non-Derivative Transactions at Cyclacel Pharmaceuticals, Inc. (CYCC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 31, 2023, Kirschbaum Mark's relationship to Cyclacel Pharmaceuticals, Inc. (CYCC) is Officer (Chief Medical Officer), and currently has 31,200 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYCC insiders.
Data Source: SEC.
Kirschbaum Mark - Insider Non-Derivative Transactions at CYCC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 1, 2023 | Acquisition -- (Common Stock) | 31200 | 0 | 31200 |